The New Round of Worldwide Biotech Companies’ Executives
ImmunoCellular Therapeutics ( $IMUC ) announced Gary S. Titus joined the company's Board of Directors. Titus now works as senior vice president and CFO of SciClone Pharmaceuticals ($SCLN ).
Coronado Biosciences ($CNDO) tapped Harlan F. Weisman as the company's new chairman and CEO. Weisman has been a director for the company since August 2012, and most recently worked at Johnson & Johnson ( $JNJ ). Bobby W. Sandage, Jr., will continue in his role as president and a member of the Board of Directors.
SciFluor Life Sciences welcomed Ben C. Askew as vice president, research. Askew joins the company from Third Rock Ventures , where he served as entrepreneur-in-residence.
NewLink Genetics ( $NLNK ) tapped Brian Wiley to serve as vice president of business development. Wiley has held management positions at Celgene ( $CELG ) and Gloucester Pharmaceuticals, among others.
Alexza Pharmaceuticals ( $ALXA ) announced J. Kevin Buchi has been appointed to the company's Board of Directors. Buchi was corporate vice president, global branded products, at Teva Pharmaceutical Industries ( $TEVA ).
Omicia appointed Mike Aicher as CEO and a member of the company's Board of Directors. Prior to joining the company, Aicher was CEO of National Genetics Institute, a company he co-founded in 1991.
Article Link: The New Round of Worldwide Biotech Companies’ ExecutivesTags: ImmunoCellular Therapeutics, Coronado Biosciences, Johnson & Johnson, SciFluor Life Sciences, NewLink Genetics, Alexza Pharmaceuticals, Omicia